CS logo
small CS logo
Florida Hospital Cancer Institute

Orlando, Florida, United States
Cancer treatment center in Orlando, Florida
2501 N Orange Ave, Orlando, FL 32804

About Florida Hospital Cancer Institute


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
SCRI Development Innovations, LLC
32
Children's Oncology Group
22
Alliance for Clinical Trials in Oncology
17
Novartis Pharmaceuticals
7
Celgene
5
Hoffmann-La Roche
5
Seagen Inc.
4
Clovis Oncology, Inc.
3
Eli Lilly and Company
3
Genelux Corporation
3
Genentech, Inc.
3
Total Rows: 60

Clinical Trials at Florida Hospital Cancer Institute


During the past decade, Florida Hospital Cancer Institute conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 51 clinical trials were completed, i.e. on average, 137.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 15 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years773310103344444422661010777766555533Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
1994-09-01
2007-03-01
Completed
31
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
1994-09-01
2006-07-01
Completed
270
Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
1996-01-01
2006-02-01
Completed
203
Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
1995-07-01
2003-08-01
Completed
3,031
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
1998-04-01
2007-03-01
Completed
69
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
1997-08-01
2011-01-01
Completed
483
Combination Chemotherapy in Treating Children With Neuroblastoma
1988-03-01
2011-01-01
Completed
573
Surgery in Treating Children With Neuroblastoma
1998-03-01
2006-03-01
Completed
968

Rows per page:

1–100 of 162

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Florida Hospital Cancer Institute" #1 sponsor was "SCRI Development Innovations, LLC" with 32 trials, followed by "Children's Oncology Group" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "Novartis Pharmaceuticals" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 74 different institutions and companies that sponsored additional 60 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Hospital Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "Genentech, Inc." with 12 trials as a collaborator, "Novartis" with 7 trials as a collaborator, "Merck Sharp & Dohme LLC" with 6 trials as a collaborator and "Blood and Marrow Transplant Clinical Trials Network" with 4 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 38 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSCRI DevelopmentInnovations, LLC: 32SCRI DevelopmentInnovations, LLC: 32Children's Oncology Group: 22Children's Oncology Group: 22Alliance for ClinicalTrials in Oncology: 17Alliance for ClinicalTrials in Oncology: 17Novartis Pharmaceuticals: 7Novartis Pharmaceuticals: 7Celgene: 5Celgene: 5Hoffmann-La Roche: 5Hoffmann-La Roche: 5Seagen Inc.: 4Seagen Inc.: 4Clovis Oncology, Inc.: 3Clovis Oncology, Inc.: 3Eli Lilly and Company: 3Eli Lilly and Company: 3Genelux Corporation: 3Genelux Corporation: 3

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 48National CancerInstitute (NCI): 48Genentech, Inc.: 12Genentech, Inc.: 12Novartis: 7Novartis: 7Merck Sharp & Dohme LLC: 6Merck Sharp & Dohme LLC: 6Blood and MarrowTransplant Clinical TrialsNetwork: 4Blood and MarrowTransplant Clinical TrialsNetwork: 4GlaxoSmithKline: 4GlaxoSmithKline: 4Amgen: 3Amgen: 3Cancer and LeukemiaGroup B: 3Cancer and LeukemiaGroup B: 3Celgene: 3Celgene: 3Celgene Corporation: 3Celgene Corporation: 3

Clinical Trials Conditions at Florida Hospital Cancer Institute


According to Clinical.Site data, the most researched conditions in "Florida Hospital Cancer Institute" are "Leukemia" (13 trials), "Ovarian Cancer" (11 trials), "Breast Cancer" (10 trials), "Lung Cancer" (8 trials) and "Lymphoma" (8 trials). Many other conditions were trialed in "Florida Hospital Cancer Institute" in a lesser frequency.

Clinical Trials Intervention Types at Florida Hospital Cancer Institute


Most popular intervention types in "Florida Hospital Cancer Institute" are "Drug" (143 trials), "Biological" (30 trials), "Procedure" (16 trials), "Radiation" (15 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (16 trials), "radiation therapy" (13 trials), "filgrastim" (12 trials), "Bevacizumab" (10 trials) and "Paclitaxel" (10 trials). Other intervention names were less common.

Clinical Trials Genders at Florida Hospital Cancer Institute


The vast majority of trials in "Florida Hospital Cancer Institute" are 128 trials for "All" genders, 30 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Florida Hospital Cancer Institute


Currently, there are NaN active trials in "Florida Hospital Cancer Institute". undefined are not yet recruiting, 14 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 104 completed trials in Florida Hospital Cancer Institute, 1 suspended trials, and 26 terminated clinical trials to date.
Out of the total trials that were conducted in Florida Hospital Cancer Institute, 22 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 98Phase 2: 98Phase 3: 47Phase 3: 47Phase 1: 22Phase 1: 22Not Applicable: 5Not Applicable: 5Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 104Completed: 104Terminated: 26Terminated: 26Recruiting: 14Recruiting: 14Active, not recruiting: 8Active, not recruiting: 8Unknown status: 5Unknown status: 5No longer available: 4No longer available: 4Suspended: 1Suspended: 1